These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 10512760)
1. The cytoplasmic domain of C-CAM1 tumor suppressor is necessary and sufficient for suppressing the tumorigenicity of prostate cancer cells. Estrera VT; Luo W; Phan D; Earley K; Hixson DC; Lin SH Biochem Biophys Res Commun; 1999 Oct; 263(3):797-803. PubMed ID: 10512760 [TBL] [Abstract][Full Text] [Related]
2. Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM1): the adhesion and growth suppression are mediated by different domains. Luo W; Wood CG; Earley K; Hung MC; Lin SH Oncogene; 1997 Apr; 14(14):1697-704. PubMed ID: 9135071 [TBL] [Abstract][Full Text] [Related]
3. Association of an 80 kDa protein with C-CAM1 cytoplasmic domain correlates with C-CAM1-mediated growth inhibition. Luo W; Earley K; Tantingco V; Hixson DC; Liang TC; Lin SH Oncogene; 1998 Mar; 16(9):1141-7. PubMed ID: 9528856 [TBL] [Abstract][Full Text] [Related]
4. Function and therapeutic implication of C-CAM cell-adhesion molecule in prostate cancer. Lin SH; Pu YS Semin Oncol; 1999 Apr; 26(2):227-33. PubMed ID: 10597733 [TBL] [Abstract][Full Text] [Related]
5. Schedule-dependence of C-CAM1 adenovirus gene therapy in a prostate cancer model. Lin SH; Pu YS; Luo W; Wang Y; Logothetis CJ Anticancer Res; 1999; 19(1A):337-40. PubMed ID: 10226564 [TBL] [Abstract][Full Text] [Related]
6. cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function. Izzi L; Turbide C; Houde C; Kunath T; Beauchemin N Oncogene; 1999 Sep; 18(40):5563-72. PubMed ID: 10523833 [TBL] [Abstract][Full Text] [Related]
7. Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model. Kleinerman DI; Dinney CP; Zhang WW; Lin SH; Van NT; Hsieh JT Cancer Res; 1996 Aug; 56(15):3431-5. PubMed ID: 8758907 [TBL] [Abstract][Full Text] [Related]
8. C-CAM1 expression: differential effects on morphology, differentiation state and suppression of human PC-3 prostate carcinoma cells. Comegys MM; Carreiro MP; Brown JF; Mazzacua A; Flanagan DL; Makarovskiy A; Lin SH; Hixson DC Oncogene; 1999 May; 18(21):3261-76. PubMed ID: 10359532 [TBL] [Abstract][Full Text] [Related]
9. Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches. Hsieh JT; Luo W; Song W; Wang Y; Kleinerman DI; Van NT; Lin SH Cancer Res; 1995 Jan; 55(1):190-7. PubMed ID: 7805032 [TBL] [Abstract][Full Text] [Related]
10. Structural analysis of the C-CAM1 molecule for its tumor suppression function in human prostate cancer. Hsieh JT; Earley K; Pong RC; Wang Y; Van NT; Lin SH Prostate; 1999 Sep; 41(1):31-8. PubMed ID: 10440873 [TBL] [Abstract][Full Text] [Related]
11. Structure and function of C-CAM1: effects of the cytoplasmic domain on cell aggregation. Lin SH; Luo W; Earley K; Cheung P; Hixson DC Biochem J; 1995 Oct; 311 ( Pt 1)(Pt 1):239-45. PubMed ID: 7575460 [TBL] [Abstract][Full Text] [Related]
12. C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers. Wang L; Lin SH; Wu WG; Kemp BL; Walsh GL; Hong WK; Mao L Clin Cancer Res; 2000 Aug; 6(8):2988-93. PubMed ID: 10955775 [TBL] [Abstract][Full Text] [Related]
13. Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: a preclinical study. Kleinerman DI; Zhang WW; Lin SH; Nguyen TV; von Eschenbach AC; Hsieh JT Cancer Res; 1995 Jul; 55(13):2831-6. PubMed ID: 7796410 [TBL] [Abstract][Full Text] [Related]
14. Expression and androgen regulation of C-CAM cell adhesion molecule isoforms in rat dorsal and ventral prostate. Makarovskiy AN; Pu YS; Lo P; Earley K; Paglia M; Hixson DC; Lin SH Oncogene; 1999 May; 18(21):3252-60. PubMed ID: 10359531 [TBL] [Abstract][Full Text] [Related]
15. Tumor-suppressive activity of CD66a in prostate cancer. Luo W; Tapolsky M; Earley K; Wood CG; Wilson DR; Logothetis CJ; Lin SH Cancer Gene Ther; 1999; 6(4):313-21. PubMed ID: 10419049 [TBL] [Abstract][Full Text] [Related]
16. Enhanced suppression of prostate tumor growth by combining C-CAM1 gene therapy and angiogenesis inhibitor TNP-470. Pu YS; Do KA; Luo W; Logothetis CJ; Lin SH Anticancer Drugs; 2002 Aug; 13(7):743-9. PubMed ID: 12187331 [TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of human cell--cell adhesion molecule 1 (C-CAM1) expressed in insect cells. Phan D; Han E; Birrell G; Bonnal S; Duggan L; Esumi N; Gutstein H; Li R; Lopato S; Manogaran A; Pollak ES; Ray A; Reddi PP; Reichert AS; Struffi P; Tiscornia G; Ximenez-Fyvie LA; Zhang H; Lin SH Protein Expr Purif; 2001 Mar; 21(2):343-51. PubMed ID: 11237697 [TBL] [Abstract][Full Text] [Related]
18. Homophilic intercellular adhesion mediated by C-CAM is due to a domain 1-domain 1 reciprocal binding. Wikström K; Kjellström G; Obrink B Exp Cell Res; 1996 Sep; 227(2):360-6. PubMed ID: 8831574 [TBL] [Abstract][Full Text] [Related]
19. Optimal ratios of biliary glycoprotein isoforms required for inhibition of colonic tumor cell growth. Turbide C; Kunath T; Daniels E; Beauchemin N Cancer Res; 1997 Jul; 57(13):2781-8. PubMed ID: 9205090 [TBL] [Abstract][Full Text] [Related]
20. Tumor growth suppression by adenovirus-mediated introduction of a cell-growth-suppressing gene tob in a pancreatic cancer model. Yanagie H; Tanabe T; Sumimoto H; Sugiyama H; Matsuda S; Nonaka Y; Ogiwara N; Sasaki K; Tani K; Takamoto S; Takahashi H; Eriguchi M Biomed Pharmacother; 2009 May; 63(4):275-86. PubMed ID: 18657378 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]